tiprankstipranks
Trending News
More News >
Caris Life Sciences, Inc. (CAI)
NASDAQ:CAI
US Market

Caris Life Sciences, Inc. (CAI) Ratios

Compare
128 Followers

Caris Life Sciences, Inc. Ratios

CAI's free cash flow for Q3 2025 was $0.68. For the 2025 fiscal year, CAI's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 20
Liquidity Ratios
Current Ratio
9.93 1.30 2.55 3.77 0.67
Quick Ratio
9.36 1.06 2.04 3.43 0.67
Cash Ratio
8.76 0.39 0.59 0.78 0.17
Solvency Ratio
-0.26 -0.08 -0.11 -0.11 0.07
Operating Cash Flow Ratio
0.45 -1.48 -2.90 -2.09 0.86
Short-Term Operating Cash Flow Coverage
233.99 -4.09 -1.65K -5.41 1.51
Net Current Asset Value
$ 348.04M$ -2.63B$ -2.32B$ -1.90B$ -1.70B
Leverage Ratios
Debt-to-Assets Ratio
0.43 1.23 0.53 0.38 0.67
Debt-to-Equity Ratio
0.89 -0.17 -0.10 -0.16 2.49
Debt-to-Capital Ratio
0.47 -0.20 -0.11 -0.19 0.71
Long-Term Debt-to-Capital Ratio
0.44 -0.15 -0.08 -0.11 0.69
Financial Leverage Ratio
2.06 -0.14 -0.19 -0.42 3.72
Debt Service Coverage Ratio
-1.89 -1.66 -8.21 -3.09 0.82
Interest Coverage Ratio
-0.16 -5.14 -10.11 -11.83 2.26
Debt to Market Cap
0.06 0.05 0.02 0.03 3.47
Interest Debt Per Share
1.67 1.86 0.98 1.17 100.69
Net Debt to EBITDA
3.79 -1.97 -0.62 -0.67 8.39
Profitability Margins
Gross Profit Margin
61.30%43.37%29.17%30.96%62.64%
EBIT Margin
-20.14%-56.24%-101.20%-113.80%48.91%
EBITDA Margin
-16.61%-44.38%-85.19%-95.13%68.62%
Operating Profit Margin
-1.41%-62.37%-104.38%-122.16%47.31%
Pretax Profit Margin
-28.90%-68.38%-111.53%-124.12%27.97%
Net Profit Margin
-28.90%-68.38%-111.53%-124.12%9.43%
Continuous Operations Profit Margin
-28.90%-68.38%-111.53%-124.12%9.43%
Net Income Per EBT
100.00%100.00%100.00%100.00%33.72%
EBT Per EBIT
2049.53%109.63%106.84%101.61%59.13%
Return on Assets (ROA)
-15.24%-82.01%-82.69%-44.72%1.06%
Return on Equity (ROE)
26.98%11.28%15.92%18.85%3.95%
Return on Capital Employed (ROCE)
-0.81%-144.20%-100.56%-54.39%6.07%
Return on Invested Capital (ROIC)
-0.81%-105.17%-98.47%-49.52%5.49%
Return on Tangible Assets
-15.55%-86.90%-86.75%-45.96%1.06%
Earnings Yield
-2.30%-3.95%-4.79%-4.50%5.52%
Efficiency Ratios
Receivables Turnover
19.45 4.67 5.54 6.43 2.04
Payables Turnover
6.93 8.40 8.13 6.54 29.97
Inventory Turnover
4.07 5.90 4.43 3.80 0.00
Fixed Asset Turnover
8.11 4.01 2.08 1.87 0.17
Asset Turnover
0.53 1.20 0.74 0.36 0.11
Working Capital Turnover Ratio
0.69 4.17 1.16 0.00 5.54
Cash Conversion Cycle
55.66 96.55 103.50 97.07 166.96
Days of Sales Outstanding
18.77 78.13 65.93 56.80 179.14
Days of Inventory Outstanding
89.58 61.86 82.49 96.04 0.00
Days of Payables Outstanding
52.69 43.45 44.91 55.77 12.18
Operating Cycle
108.35 139.99 148.42 152.84 179.14
Cash Flow Ratios
Operating Cash Flow Per Share
0.14 -0.96 -1.08 -1.12 15.43
Free Cash Flow Per Share
0.10 -1.00 -1.17 -1.29 3.21
CapEx Per Share
0.04 0.03 0.09 0.17 12.23
Free Cash Flow to Operating Cash Flow
0.71 1.03 1.08 1.15 0.21
Dividend Paid and CapEx Coverage Ratio
3.44 -29.04 -12.37 -6.76 1.17
Capital Expenditure Coverage Ratio
3.44 -29.04 -12.37 -6.76 1.26
Operating Cash Flow Coverage Ratio
0.09 -0.58 -1.27 -1.05 0.16
Operating Cash Flow to Sales Ratio
0.07 -0.59 -0.90 -1.11 0.94
Free Cash Flow Yield
0.42%-3.56%-4.19%-4.60%11.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-43.54 -25.30 -20.89 -22.24 18.12
Price-to-Sales (P/S) Ratio
12.59 17.30 23.29 27.60 1.71
Price-to-Book (P/B) Ratio
13.66 -2.85 -3.32 -4.19 0.72
Price-to-Free Cash Flow (P/FCF) Ratio
240.20 -28.11 -23.89 -21.75 8.73
Price-to-Operating Cash Flow Ratio
170.25 -29.08 -25.83 -24.97 1.81
Price-to-Earnings Growth (PEG) Ratio
-2.25 -0.52 -1.31 0.00 -1.83
Price-to-Fair Value
13.66 -2.85 -3.32 -4.19 0.72
Enterprise Value Multiple
-72.00 -40.94 -27.96 -29.68 10.88
Enterprise Value
6.21B 7.49B 7.29B 7.30B 2.19B
EV to EBITDA
-72.00 -40.94 -27.96 -29.68 10.88
EV to Sales
11.96 18.17 23.82 28.23 7.46
EV to Free Cash Flow
228.19 -29.53 -24.43 -22.25 38.13
EV to Operating Cash Flow
161.77 -30.55 -26.41 -25.54 7.92
Tangible Book Value Per Share
1.63 -9.89 -8.50 -6.76 39.12
Shareholders’ Equity Per Share
1.70 -9.81 -8.42 -6.68 39.12
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 0.00 0.00 0.02
Revenue Per Share
1.84 1.62 1.20 1.01 16.38
Net Income Per Share
-0.53 -1.11 -1.34 -1.26 1.55
Tax Burden
1.00 1.00 1.00 1.00 0.34
Interest Burden
1.44 1.22 1.10 1.09 0.57
Research & Development to Revenue
0.13 0.28 0.38 0.39 0.00
SG&A to Revenue
0.33 0.42 0.50 0.60 0.09
Stock-Based Compensation to Revenue
0.11 0.05 0.05 0.09 <0.01
Income Quality
-0.26 0.87 0.81 0.89 9.99
Currency in USD